Takeda Pharmaceutical Co Ltd (NYSE:TAK)
| 14.82 Delayed Data As of Dec 02 |  -0.05 / -0.34%Today’s Change | 12.28 Today|||52-Week Range 15.36 | +8.73% Year-to-Date |
Latest TAK News | Press Releases
| Are Tech Layoffs Going to Be a Headache for Alexandria Real Estate Equities? Nov 30 / MotleyFool.com - Paid Partner Content | Why Puma Biotechnology's Shares Jumped 20% on Monday Nov 21 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 14.87 |
| Today’s open | 14.62 |
| Day’s range | 14.62 - 14.82 |
| Volume | 1,637,936 |
| Average volume (3 months) | 2,761,127 |
| Market cap | $46.9B |
Data as of 4:00pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | -42.31% |
| Earnings growth (this year) | +21.39% |
| Earnings growth (next 5 years) | +17.50% |
| Revenue growth (last year) | +5.34% |
| P/E ratio | 29.2 |
| Price/Sales | 1.42 |
| Price/Book | 0.98 |
Competitors
| ---- |
| ---- |
| ---- |
| ---- |
Data as of 12/30/1899
Financials
| Next reporting date | February 2, 2023 |
| EPS forecast (this quarter) | $0.33 |
| Annual revenue (last year) | $31.8B |
| Annual profit (last year) | $2.0B |
| Net profit margin | 6.45% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Osaka, Osaka |
Forecasts
